secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profusa, Inc. (PFSA)
CIK:        0001859807
Form:       8-K
Filed at:   2026-08-20T12:32:30+00:00
Accession:  0001213900-26-091905
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profusa Q2 net loss $8.8M; cash $719K; progress on G3 option
------------------------------------------------------------

- Net loss Q2 2026 $(8.8)M vs $(2.2)M year-ago; six-month loss $(12.2)M vs $(5.1)M.
- Cash at June 30 $719K; total assets $1.0M; stockholders' deficit $(27.1)M.
- Debt/liability holders executed $10.7M Series A Convertible Exchange Agreements; $4.57M converted to preferred.
- Borrowed $650K for working capital; 4:1 reverse stock split effective Aug 18, 2026.
- G3 audits expected by mid-September; combined company to operate as public diagnostics with CLIA labs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859807/000121390026091905/0001213900-26-091905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859807/000121390026091905/ea0302812-8k_profusa.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-091905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer